Advertisement

The PILRA G78R Variant Correlates with Higher HSV-1-Specific IgG Titers in Alzheimer’s Disease

  • Simone AgostiniEmail author
  • Andrea Saul Costa
  • Roberta Mancuso
  • Franca Rosa Guerini
  • Raffaello Nemni
  • Mario Clerici
Brief Communication

Abstract

Alzheimer’s disease (AD) is a neurodegenerative disease characterized by a progressive decline in cognitive performance; Mild Cognitive Impairment (MCI) is instead an objective decline in cognitive performance that does not reach pathology. Paired immunoglobulin-like type 2 receptor alpha (PILRA) is a cell surface inhibitory receptor that was recently suggested to be involved in AD pathogenesis. In particular, the arginine-to-glycine substitution in position 78 (R78, rs1859788) was shown to be protective against AD. Herpes simplex virus type 1 (HSV-1) infection is suspected as well to be involved in AD. Interestingly, HSV-1 uses PILRA to infect cells, and HSV-1 infects more efficiently PIRLA G78 compared to R78 macrophages. We analyzed PILRA rs1859788 polymorphism and HSV-1 humoral immune responses in AD (n = 61) and MCI patients (n = 48), and in sex and age matched healthy controls (HC; n = 57). The rs1859788 PILRA genotype distribution was similar among AD, MCI and HC; HSV-1 antibody (Ab) titers were increased in AD and MCI compared to HC (p < 0.05 for both comparisons). Notably, HSV-1-specific IgG1 were significantly increased in AD patients carrying PILRA R78 rs1859788 AA than in those carrying G78 AG or GG (p = 0.01 for both comparisons), and the lowest titers of HSV-1-specific IgG1 were observed in rs1859788 GG AD. HSV-1 IgG are increased in AD patients with the protective R78 PILRA genotype. Because in AD patients brain atrophy is inversely correlated with HSV-1-specific IgG titers, results herein suggest a possible link between two important genetic and infective factors suspected to be involved in AD pathogenesis.

Keywords

HSV-1 Alzheimer’s disease Mild Cognitive Impairment IgG1 Paired immunoglobulin-like type 2 receptor alpha (PILRA) 

Notes

Acknowledgements

This work was supported by 2018–2019 Ricerca Corrente (Italian Ministry of Health).

Author Contributions

MC, SA, and ASC designed the experiment; RN recruited subjects and collected biological samples; ASC, RM, and SA performed experiments and data collection; ASC, FG, and SA analyzed the data; and MC, ASC, and SA interpreted the data and drafted the manuscript.

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of Fondazione Don Carlo Gnocchi—ONLUS committee (reference number: 12_21/06/2018) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants, or their legal guardians, included in the study.

Research Involving Animals

This article does not contain any studies with animals performed by any of the authors.

References

  1. Agostini S, Mancuso R, Baglio F, Cabinio M, Hernis A, Costa AS, Calabrese E, Nemni R, Clerici M (2016) High avidity HSV-1 antibodies correlate with absence of amnestic mild cognitive impairment conversion to Alzheimer’s disease. Brain Behav Immun 58:254–260CrossRefGoogle Scholar
  2. Agostini S, Mancuso R, Baglio F, Clerici M (2017) A protective role for herpes simplex virus type-1-specific humoral immunity in Alzheimer’s disease. Expert Rev Anti Infect Ther 15:89–91CrossRefGoogle Scholar
  3. Agostini S, Mancuso R, Hernis A, Costa AS, Nemni R, Clerici M (2018) HSV-1-specific IgG subclasses distribution and serum neutralizing activity in Alzheimer’s disease and in mild cognitive impairment. J Alzheimers Dis 63:131–138CrossRefGoogle Scholar
  4. Ball MJ (1982) Limbic predilection of Alzheimer’s dementia: is reactivated herpes virus involved? Can J Neurol Sci 9:303–306CrossRefGoogle Scholar
  5. Costa AS, Agostini S, Guerini FR, Mancuso R, Zanzottera M, Ripamonti E, Racca V, Nemni R, Clerici M (2017) Modulation of immune responses to herpes simplex virus type 1 by IFNL3 and IRF7 polymorphisms: a study in Alzheimer’s disease. J Alzheimers Dis 60:1055–1063CrossRefGoogle Scholar
  6. Gilljam G, Sundqvist VA, Linde A, Philstedt P, Eklund AE, Wahren B (1985) Sensitive analytic ELISAs for subclass herpes virus IgG. J Virol Methods 10:203–214CrossRefGoogle Scholar
  7. Harris SA, Harris EA (2018) Molecular mechanisms for herpes simplex virus type 1 pathogenesis in Alzheimer’s disease. Front Aging Neurosci 10:48CrossRefGoogle Scholar
  8. Itzhaki RF, Lathe R, Balin BJ, Ball MJ, Bearer EL, Braak H, Bullido MJ, Carter C, Clerici M, Cosby SL, Del Tredici K, Field H, Fulop T, Grassi C, Griffin WS, Haas J, Hudson AP, Kamer AR, Kell DB, Licastro F, Letenneur L, Lovheim H, Mancuso R, Miklossy J, Otth C, Palamara AT, Perry G, Preston C, Pretorius E, Strandberg T, Tabet N, Taylor-Robinson SD, Whittum-Hudson JA (2016) Microbes and Alzheimer’s disease. J Alzheimers Dis 51:979–984CrossRefGoogle Scholar
  9. Kohyama M, Matsuoka S, Shida K, Sugihara F, Aoshi T, Kishida K, Ishii KJ, Arase H (2016) Monocyte infiltration into obese and fibrilized tissues is regulated by PILRα. Eur J Immunol 46:1214–1223CrossRefGoogle Scholar
  10. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45:1452–1458CrossRefGoogle Scholar
  11. Lovheim H, Gilthorpe J, Adolfsson R, Nilsson LG, Elgh F (2015) Reactivated herpes simplex infection increases the risk of Alzheimer’s disease. Alzheimers Dement 11:593–599CrossRefGoogle Scholar
  12. Mancuso R, Baglio F, Cabinio M, Calabrese E, Hernis A, Nemni R, Clerici M (2014a) Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volumes in Alzheimer’s disease. J Alzheimers Dis 38:741–745CrossRefGoogle Scholar
  13. Mancuso R, Baglio F, Agostini S, Cabinio M, Laganà MM, Hernis A, Margaritella N, Guerini FR, Zanzottera M, Nemni R, Clerici M (2014b) Relationship between herpes simplex virus-1-specific antibody titers and cortical brain damage in Alzheimer’s disease and amnestic mild cognitive impairment. Front Aging Neurosci 6:285CrossRefGoogle Scholar
  14. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Moris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer’s disease: Reccomendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269CrossRefGoogle Scholar
  15. Mousseau DD, Banville D, L’Abbe D, Bouchard P, Shen SH (2000) PILRα, a novel immunoreceptor tyrosine-based inhibitory motif-bearing protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with the truncated counterpart PILRb. J Biol Chem 275:4467–4474CrossRefGoogle Scholar
  16. Petersen RC (2004) Mild cognitive impairment as a diagnostic entry. J Intern Med 256:183–194CrossRefGoogle Scholar
  17. Rathore N, Ramani SR, Pantua H, Payandeh J, Bhangale T, Wuster A, Kapoor M, Sun Y, Kapadia SB, Gonzales L, Zarrin AA, Goate A, Hansen DV, Behrens TW, Graham RR (2018) Paired immunoglobulin-like type 2 receptor alpha G78R variant alters ligand binding and confers protection to Alzheimer’s disease. PLoS Genet 14:e1007427CrossRefGoogle Scholar
  18. Roses AD (1998) Alzheimer diseases: a model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases. Am J Med Genet 81:49–57CrossRefGoogle Scholar
  19. Satoh T, Arii J, Suenaga T, Wang J, Kogure A, Uehori J, Arase N, Shiratori I, Tanaka S, Kawaguchi Y, Spear PG, Lanier LL, Arase H (2008) PILRα is a herpes simplex virus-1 entry co-receptor that associates with glycoprotein B. Cell 132:935–944CrossRefGoogle Scholar
  20. Sun Y, Caplazi P, Zhang J, Mazloom A, Kummerfeld S, Quinones G, Senger K, Lesch J, Peng I, Sebrell A, Luk W, Lu Y, Lin Z, Barck K, Young J, Del Rio M, Lehar S, Asghari V, Lin W, Mariathasan S, DeVoss J, Misaghi S, Balazs M, Sai T, Haley B, Hass PE, Xu M, Ouyang W, Martin F, Lee WP, Zarrin AA (2014) PILRa negatively regulates mouse inflammatory arthtritis. J Immunol 193:860–870CrossRefGoogle Scholar
  21. Tangalos EG, Petersen RC (2018) Mild cognitive impairment in geriatrics. Clin Geriatr Med 34:563–589CrossRefGoogle Scholar
  22. Wang J, Shiratori I, Uehori J, Ikawa M, Arase H (2014) Neutrophil infiltration during inflammation is regulated by PILRA via modulation of integrin acitvation. Nat Immunol 2:860–870Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.IRCCS Fondazione Don Carlo GnocchiMilanItaly
  2. 2.Department of Pathophysiology and TransplantationUniversity of MilanMilanItaly

Personalised recommendations